NCT00186433

A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 49 (actual)
• Sponsor: Stanford University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

1. To determine the prognostic implication of plasma Epstein-Bar Virus (EBV) DNA concentrations, as measured by quantitative polymerase chain reaction (PCR) in patients with nasopharyngeal carcinoma (NPC). 2. To relate pretreatment plasma EBV DNA concentration to WHO classification of these tumors both in endemic and non-endemic areas. 3. To determine whether pretreatment plasma EBV DNA can serve as a prognostic factor for both endemic and non-endemic patient populations.

Conditions

• Mouth Cancer
• Lip Cancer
• Throat Cancer
• Lip Neoplasms
• Head and Neck Cancers

Timeline

• Start date: 2001-11-01
• Primary completion: 2013-06-01
• Completion: 2013-06-01
• First posted: 2005-09-16
• Last updated: 2015-05-27

Locations

1 site across 1 country: United States